درباره این اپیزود
Medical technology continues to transform patient care, from minimally invasive heart procedures to robotic surgery. Yet despite this progress, the sector has faced a challenging few years amid policy uncertainty, hospital capacity constraints and shifting investor sentiment. In this episode, Katie Boyce sits down with Investment Manager Paul Loudon to discuss why medtech has historically been fertile ground for long-term investors, how Walter Scott assesses recent challenges, and where the most compelling opportunities lie today.
Key takeaways
- Many of the sector's recent challenges appear cyclical rather than structural in nature.
- Concerns over obesity drugs and healthcare spending may have overshadowed resilient demand trends.
- Strong research and company engagement help uncover attractive long-term opportunities.
To watch the full video version of this conversation, head to our website at walterscott.com/research.
Speakers
- Katie Boyce, Investment Writer
- Paul Loudon, Investment Manager
Resources
Article from Research Journal 16 - Robotic surgery's next frontier: https://www.walterscott.com/research/articles/Robotic_surgery_next_frontier/
Our podcast episodes are intended solely for institutional investors, investment professionals, investment consultants and financial intermediaries only and should not be construed as investment advice or a recommendation. Any stock examples discussed are given in the context of the theme being explored, and the views expressed are those of the presenters at the time of the recording.
